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traditional cartilage loss markers (volume/thickness). We propose
a novel efﬁcacy marker, Cartilage Activity, that quantiﬁes deviation
from homeostasis, and validate the Activity marker on three sub-
cohorts with respect to sensitivity to change.
Methods: Cartilage Activity was deﬁned as the mean absolute longi-
tudinal change in thickness quantiﬁed over one or more compartments.
The Activity marker was quantiﬁed using thickness maps from a fully
automatic segmentation and analysis framework (KneeIQ). The marker
was validated on three populations: A) 139 subjects with 0.18T MRI
acquired at baseline and after 21 months at the Center for Basic and
Clinical Research in Copenhagen (CCBR), B) 500 subjects selected by
patient ID order from the Osteoarthritis Initiative (OAI) study with the
sagittal DESS sequence acquired for the right knee from 3T MRI at
baseline and after 1 year (OAI1), and C) the 455 subjects from OAI with
publicly available sub-regional thickness measurements for the right
knee provided by Chondrometrics available at baseline and 1 year from
same OAI project. For all cohorts, knees with missing radiographic
Kellgren & Lawrence score (KL) or KL 4 were removed. On these sub-
cohorts, the sensitivity to change was evaluated by comparing longi-
tudinal marker changes between knees with and without radiographic
OA (ROA) and by evaluating standardized response mean (SRM). We
considered KL>1 to be ROA, and KL 0-1 to be pre-ROA. The Activity
marker was evaluated against the mean thickness marker across the
total area of bone (denoted Thickness). For the CCBR cohort, only the
medial compartments for tibia (MT) and femur (MF) were computed
and combined (MFT). For the OAI sub-cohorts, also lateral compart-
ments (LT and LF) were computed and combined (LFT) and in the whole
knee (FTJ).
Results: The three sub-cohorts are summarized in the table below. The
percentages of females in each sub-cohort were 48%, 64%, and 56%.Sub-cohort characteristics (given as mean  std)
KL 0 KL 1 KL 2 KL3
CCBR Knee count 138 84 24 21
Age (years) 56  16 58  15 62  15 68  11
BMI (kg/m2) 26  4 26  4 26  4 26  2
OAI1 Knee count 189 84 140 73
Age (years) 62  9 65  9 64  9 66  9
BMI (kg/m2) 27  5 29  4 29  4 29  5
OAI2 Knee count 27 43 200 174
Age (years) 59  10 63  11 60  9 63  9
BMI (kg/m2) 30  4 29  5 30  5 30  4The differences in longitudinal changes between the pre-ROA and ROA
knees are analyzed for both Thickness and Activity markers in the Table.
Group differences are given as area under the ROC and as p-value from
a Rank-sum test (* is p<0.05, ** p<0.001, *** p<0.00001).Thickness and Activity changes in pre-ROA against OA (KL>1) in three
sub-cohorts:
CCBR (n¼267) OAI1 (n¼486) OAI2 (n¼444)
Thickness Activity Thickness Activity Thickness Activity
MT 0.55 0.82** 0.54 0.63*** 0.52 0.68***
MF 0.70** 0.84** 0.54 0.70*** 0.53 0.66**
LT - - 0.55* 0.61*** 0.54 0.57
LF - - 0.52 0.66*** 0.54 0.69***
MFT 0.67** 0.85** 0.55* 0.69*** 0.53 0.70***
LFT - - 0.55 0.66*** 0.55 0.67**
FTJ - - 0.56* 0.70**** 0.56 0.74***Further, the responsiveness to change is illustrated for groups with
different baseline KL in the ﬁgure below. For the Activity marker, the
corresponding SRMs were between 1.4 and 5.1 for all three sub-cohorts.ĂConclusions: The results demonstrated the sensitivity of the Cartilage
Activity marker for monitoring progression of OA at different stages of
the disease. The robustness of the marker was demonstrated by vali-
dations on both high-ﬁeld and low-ﬁeld MRI in quite large populations.
The Activity marker needs to be validated in a treatment study, but
shows great promise as a novel efﬁcacy marker.29
SERUM PERIOSTIN IS ASSOCIATED WITH PREVALENT KNEE
OSTEOARTHRITIS AND PREDICTS DISEASE PROGRESSION IN
WOMEN: THE OFELY STUDY
J.-C. Rousseau y, E. Sornay-Rendu y, C. Bertholon y, P. Garnero y,z, R.
Chapurlat y. y INSERM, Lyon, France; zCisbio Bioassays, Codolet, France
Purpose: Periostin (POSTN) is a secreted vitamin K-dependent (Gla-
containing) protein produced by osteoblasts and chondrocytes. The aim
of this study was to investigate the relationships between serum POSTN
and both prevalent and incident knee osteoarthritis in women.
Subjects and Methods:We investigated 753 women (mean age: 62.7
11.2 yr) from the OFELY (Os des Femmes de Lyon) cohort, 19.3 % being
premenopausal. Knee radiographs were performed at the ninth annual
follow-up (baseline for this analysis) and 4 years later and scored using
the Kellgren & Lawrence classiﬁcation. Progression of joint destruction
was deﬁned as an increase of KL score 1 during the 4 years follow-up.
Evaluation of the spine (X-rays), hip (self-reported) and hand OA
(clinical exam) have been performed at the same visit. Serum POSTN
was measured at baseline by ELISA (USCNK, China).
Results: Serum POSTN was signiﬁcantly lower in the 110 women with
a KL score  2 at baseline compared to the 481 controls with a KL score
< 2 (1118.9  307 ng/ml vs 1182.3  292 ng/ml, p ¼ 0.018 after
adjustment for age). During the 4 year follow-up, 181 women had
a radiological progression in their knee OA. Baseline POSTN levels were
signiﬁcantly lower in progressors than in non progressors (1140  296
vs 1182  294 ng/ml, p ¼ 0.039 after adjustment for age and for the
presence of prevalent knee, spine, hip and hand OA). For each increase
of one POSTN quartile, the risk of progression decreased by 0.82 (IC:
0.69-0.98, p ¼ 0.034) after adjustment for age and for OA at the other
anatomical sites.
Conclusions: We showed for the ﬁrst time that serum POSTN is asso-
ciated with prevalence and progression of knee OA in women.30
THREE-DIMENSIONAL KNEE BIOMECHANICS DURING GAIT PREDICT
KNEE OSTEOARTHRITIS PROGRESSION
G. Hatﬁeld, W.D. Stanish, C.L. Hubley-Kozey. Dalhousie Univ., Halifax, NS,
Canada
Purpose: Conservative interventions have been identiﬁed as the most
important healthcare need for those with knee osteoarthritis (OA).
While mechanical risk factors for knee OA progression have been
identiﬁed via large epidemiological studies, only one longitudinal
study examined the knee joint local mechanical loading environment.
They found that higher peak knee adduction moments (KAM) during
walking were associated with increased risk of knee OA progression.
While the most common gait variable reported in knee OA literature,
the peak KAM is a surrogate measure of medial compartment loading
at one point in the gait cycle, it neglects dynamic loading. Addi-
tionally, three-dimensional (3D) gait variables are related to knee OA
severity, but their association to knee OA progression is not clear. This
follow up study determined if there were differences in 3D knee
biomechanical gait patterns between those with moderate knee
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did not.
Methods: 50 patients with moderate medial compartment knee OA
underwent gait analysis at baseline. Ground reaction forces (sampled
at 1000 Hz) and segment motions (sampled at 100 Hz) were recorded
during self-selected walking. Three-dimensional knee angles and
moments were calculated using inverse dynamics. All waveforms were
time-normalized to percent of gait cycle, and moment waveforms
were amplitude-normalized to body mass. Amplitude and temporal
waveform characteristics were determined using Principal Component
Analysis (PCA) for each waveform separately (6 in total). During follow
up phone interviews 5-8 years later, 25 patients reported undergoing
TKA surgery. Unpaired Student's t-tests were used to test for differ-
ences in all baseline demographic and waveform characteristics (PC
scores) between the group that had TKA and the group that did not
(a¼0.05).
Results: There were no between-group differences in age (59 years in
TKA group vs. 57 years in no-TKA group), mass (93.5 kg vs. 93.8 kg),
body mass index (30.6 kg/m2 vs. 30.8 kg/m2), and gait speed (1.23
m/s vs. 1.27 m/s), with similar radiographic disease severity (Kellgren-
Lawrence score) distribution at baseline. The mean time between
baseline and follow up was 7.8 yrs for each group. The group that
progressed to TKA had a signiﬁcantly higher overall magnitude of the
KAM (Fig 1, PC1, p < 0.05), less of a difference between the ﬁrst peak
KAM and the mid-stance KAM (Fig 1, PC2, p < 0.05), more tibial
external rotation during mid-stance (PC4, p<0.05), and a trend
toward reduced early stance knee ﬂexion and late stance knee
extension moments (PC2, p¼0.073) than the no-TKA group at
baseline.
Conclusions: The KAM ﬁndings suggest that the group that went on to
TKA had higher overall medial compartment loading throughout the
gait cycle at baseline (PC1), and a reduced ability to unload the medial
compartment during mid-stance (PC2). These results support a cumu-
lative rather than an impulse loading mechanism for progression.
Furthermore, increased tibial external rotation (PC4) and a trend toward
altered sagittal plane moment characteristics (PC2) were found in those
that progressed. Together these ﬁndings indicate that dynamic frontal,
transverse, and sagittal plane mechanical features are related to knee
OA progression and should be considered in future prediction models of
progression.Ă31
BENEFICIAL EFFECTS OF A BRACE FOR PATELLOFEMORAL OA:
RESULTS OF A RANDOMISED TRIAL
M. Callaghan, M.J. Parkes, L.M. Forsythe, H.E. Williams, F. Stirling, D.T.
Felson. The Univ. of Manchester, Manchester, United Kingdom
Purpose: There is a pressing need for non-pharmacological interven-
tions for knee osteoarthritis (OA) and little attention has been paid to
treatments speciﬁcally for the patellofemoral joint (PFJ). There has been
only one study of patellofemoral (PF) braces which compared the same
brace with and without a patellar strap and showed no effect on pain of
the brace with a strap. In clinical practice, a relevant question is the
beneﬁt of PF bracing versus no bracing. Furthermore, using validated
knee pain instruments that measure painful activities not related to PFJ
activities may fail to detect the effects of interventions on PFJ related
pain.
We sought to examine the effect of a patella brace versus no treatment
control for 6 weeks and then brace wearing over a 12 week period for
PFJOA on pain, function and quality of life (QoL) scores.
Methods: Subjects age 40-70 years old with knee pain were included if
they had a radiographic K-L score grade 2 or 3 in the PFJ which was
greater than K-L score for the tibiofemoral compartments. Subjects had
to have symptomatic PFJOA deﬁned as pain with stair climbing,
kneeling, prolonged sitting or squatting and tenderness over lateral or
medial patellar facet on palpation or a positive patellar compression
test. Pain must have been present daily for the previous 3 months and
above a score of 40 on a 0-100mm VAS for their nominated most
aggravating activity. If they were already receiving pain medication or
physical therapy treatment they were asked to continue this during the
trial.
Subjects were randomised to either immediate treatment with Bioskin
Patellar Tracking Q Brace (Ossur UK, Manchester, England) or to delayed
treatment at 6 weeks so that the ﬁrst 6 weeks constituted a brace versus
no brace trial. All subjects, once receiving brace were assessed after 12
weeks of brace wearing.
Primary outcome measure was pain experienced during their nomi-
nated aggravating activity, on a 100mm VAS scale (0 ¼ no pain and
100 ¼ worst pain). These activities were: stair ascent, stairs descent,
squatting, kneeling, and slope walking. Secondary outcomes included
knee pain in the last week (VAS) and change in Knee Osteoarthritis
Outcome Score (KOOS) subscales for pain, function and QoL were
analysed.
Two separate analyses were performed using multiple linear regression
equations: Analysis A examined the differences between brace and no
brace control on knee pain VAS, function and QoL over the period of 6
weeks in a randomised trial. Analysis B examined the change in VAS,
function and QoL after 12 weeks of brace wearing. All analyses were by
intention-to-treat.
Results: 126 subjects with PFOA were randomised 1:1 to brace versus
no brace (mean age 55.48 (SD 7.49) years; 72 females (57%); BMI
median 29.75 (IQR 26.49 to 34.89); median baseline nominated activity
VAS score 68 (IQR 53 to 81). Nine patients were lost to follow up (7%):
Six at 6 weeks, and three at 12 weeks.
Analysis A was a between group analysis at 6 weeks comparing brace
and no brace (Table 1).
Analysis B was a within group analysis for all patients after 12 weeks
of brace wearing (Table 1). Both analyses were conﬁrmed using
multiple imputation to cater for missing observations (data not
presented).
Conclusions: This trial has shown a signiﬁcantly beneﬁcial effect of
a PF brace on pain and function for painful PFJOA. If instruments like
KOOS or WOMAC which include ratings for knee pain during activ-
ities unrelated to the PF joint had been used as the primary outcome
in this trial, the efﬁcacy of the brace would have appeared dimin-
ished.
